 | • レポートコード：MRC2012B0112 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、基底細胞癌治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。基底細胞癌治療の種類別市場規模（局所治療、ヘッジホッグ経路阻害剤療法、モース手術、その他手術、その他治療）、用途別市場規模（病院、専門クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、Taro Pharmaceuticals、Sun Pharmaceuticals、Bausch Health Companies、Mylan、 ・地域別グローバル市場分析 2015年-2020年 ・基底細胞癌治療の北米市場（アメリカ、カナダ、メキシコ） ・基底細胞癌治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・基底細胞癌治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・基底細胞癌治療の南米市場（ブラジル、アルゼンチン） ・基底細胞癌治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：局所治療、ヘッジホッグ経路阻害剤療法、モース手術、その他手術、その他治療 ・用途別分析：病院、専門クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Basal Cell Carcinoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Basal Cell Carcinoma Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Basal Cell Carcinoma Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Basal Cell Carcinoma Treatment market has been segmented into:
Topical Treatment
Hedgehog Pathway Inhibitor Therapy
Mohs Surgery
Other Surgeries
Other Treatments
By Application, Basal Cell Carcinoma Treatment has been segmented into:
Hospitals
Specialty Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Basal Cell Carcinoma Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Basal Cell Carcinoma Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Basal Cell Carcinoma Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Basal Cell Carcinoma Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Basal Cell Carcinoma Treatment Market Share Analysis
Basal Cell Carcinoma Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Basal Cell Carcinoma Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Basal Cell Carcinoma Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Basal Cell Carcinoma Treatment are:
Roche
Taro Pharmaceuticals
Sun Pharmaceuticals
Bausch Health Companies
Mylan
Among other players domestic and global, Basal Cell Carcinoma Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Basal Cell Carcinoma Treatment Market Overview
1.1 Product Overview and Scope of Basal Cell Carcinoma Treatment
1.2 Classification of Basal Cell Carcinoma Treatment by Type
1.2.1 Global Basal Cell Carcinoma Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Basal Cell Carcinoma Treatment Revenue Market Share by Type in 2019
1.2.3 Topical Treatment
1.2.4 Hedgehog Pathway Inhibitor Therapy
1.2.5 Mohs Surgery
1.2.6 Other Surgeries
1.2.7 Other Treatments
1.3 Global Basal Cell Carcinoma Treatment Market by Application
1.3.1 Overview: Global Basal Cell Carcinoma Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Global Basal Cell Carcinoma Treatment Market by Regions
1.4.1 Global Basal Cell Carcinoma Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Basal Cell Carcinoma Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Basal Cell Carcinoma Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Basal Cell Carcinoma Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Basal Cell Carcinoma Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Basal Cell Carcinoma Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Basal Cell Carcinoma Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Basal Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Taro Pharmaceuticals
2.2.1 Taro Pharmaceuticals Details
2.2.2 Taro Pharmaceuticals Major Business
2.2.3 Taro Pharmaceuticals SWOT Analysis
2.2.4 Taro Pharmaceuticals Product and Services
2.2.5 Taro Pharmaceuticals Basal Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sun Pharmaceuticals
2.3.1 Sun Pharmaceuticals Details
2.3.2 Sun Pharmaceuticals Major Business
2.3.3 Sun Pharmaceuticals SWOT Analysis
2.3.4 Sun Pharmaceuticals Product and Services
2.3.5 Sun Pharmaceuticals Basal Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bausch Health Companies
2.4.1 Bausch Health Companies Details
2.4.2 Bausch Health Companies Major Business
2.4.3 Bausch Health Companies SWOT Analysis
2.4.4 Bausch Health Companies Product and Services
2.4.5 Bausch Health Companies Basal Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan SWOT Analysis
2.5.4 Mylan Product and Services
2.5.5 Mylan Basal Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Basal Cell Carcinoma Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Basal Cell Carcinoma Treatment Players Market Share
3.2.2 Top 10 Basal Cell Carcinoma Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Basal Cell Carcinoma Treatment Revenue and Market Share by Regions
4.2 North America Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
5 North America Basal Cell Carcinoma Treatment Revenue by Countries
5.1 North America Basal Cell Carcinoma Treatment Revenue by Countries (2015-2020)
5.2 USA Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
6 Europe Basal Cell Carcinoma Treatment Revenue by Countries
6.1 Europe Basal Cell Carcinoma Treatment Revenue by Countries (2015-2020)
6.2 Germany Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
6.4 France Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Basal Cell Carcinoma Treatment Revenue by Countries
7.1 Asia-Pacific Basal Cell Carcinoma Treatment Revenue by Countries (2015-2020)
7.2 China Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
7.5 India Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
8 South America Basal Cell Carcinoma Treatment Revenue by Countries
8.1 South America Basal Cell Carcinoma Treatment Revenue by Countries (2015-2020)
8.2 Brazil Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Basal Cell Carcinoma Treatment by Countries
9.1 Middle East & Africa Basal Cell Carcinoma Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Basal Cell Carcinoma Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Basal Cell Carcinoma Treatment Market Forecast by Type (2019-2024)
10.3 Topical Treatment Revenue Growth Rate (2015-2025)
10.4 Hedgehog Pathway Inhibitor Therapy Revenue Growth Rate (2015-2025)
10.5 Mohs Surgery Revenue Growth Rate (2015-2025)
10.6 Other Surgeries Revenue Growth Rate (2015-2025)
10.7 Other Treatments Revenue Growth Rate (2015-2025)
11 Global Basal Cell Carcinoma Treatment Market Segment by Application
11.1 Global Basal Cell Carcinoma Treatment Revenue Market Share by Application (2015-2020)
11.2 Basal Cell Carcinoma Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Specialty Clinics Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Basal Cell Carcinoma Treatment Market Size Forecast (2021-2025)
12.1 Global Basal Cell Carcinoma Treatment Market Size Forecast (2021-2025)
12.2 Global Basal Cell Carcinoma Treatment Market Forecast by Regions (2021-2025)
12.3 North America Basal Cell Carcinoma Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Basal Cell Carcinoma Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Basal Cell Carcinoma Treatment Revenue Market Forecast (2021-2025)
12.6 South America Basal Cell Carcinoma Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Basal Cell Carcinoma Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Basal Cell Carcinoma Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Basal Cell Carcinoma Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Basal Cell Carcinoma Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Basal Cell Carcinoma Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Basal Cell Carcinoma Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Roche Corporate Information, Location and Competitors
Table 7. Roche Basal Cell Carcinoma Treatment Major Business
Table 8. Roche Basal Cell Carcinoma Treatment Total Revenue (USD Million) (2017-2018)
Table 9. Roche SWOT Analysis
Table 10. Roche Basal Cell Carcinoma Treatment Product and Solutions
Table 11. Roche Basal Cell Carcinoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Taro Pharmaceuticals Corporate Information, Location and Competitors
Table 13. Taro Pharmaceuticals Basal Cell Carcinoma Treatment Major Business
Table 14. Taro Pharmaceuticals Basal Cell Carcinoma Treatment Total Revenue (USD Million) (2018-2019)
Table 15. Taro Pharmaceuticals SWOT Analysis
Table 16. Taro Pharmaceuticals Basal Cell Carcinoma Treatment Product and Solutions
Table 17. Taro Pharmaceuticals Basal Cell Carcinoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Sun Pharmaceuticals Corporate Information, Location and Competitors
Table 19. Sun Pharmaceuticals Basal Cell Carcinoma Treatment Major Business
Table 20. Sun Pharmaceuticals Basal Cell Carcinoma Treatment Total Revenue (USD Million) (2017-2018)
Table 21. Sun Pharmaceuticals SWOT Analysis
Table 22. Sun Pharmaceuticals Basal Cell Carcinoma Treatment Product and Solutions
Table 23. Sun Pharmaceuticals Basal Cell Carcinoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Bausch Health Companies Corporate Information, Location and Competitors
Table 25. Bausch Health Companies Basal Cell Carcinoma Treatment Major Business
Table 26. Bausch Health Companies Basal Cell Carcinoma Treatment Total Revenue (USD Million) (2017-2018)
Table 27. Bausch Health Companies SWOT Analysis
Table 28. Bausch Health Companies Basal Cell Carcinoma Treatment Product and Solutions
Table 29. Bausch Health Companies Basal Cell Carcinoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Mylan Corporate Information, Location and Competitors
Table 31. Mylan Basal Cell Carcinoma Treatment Major Business
Table 32. Mylan Basal Cell Carcinoma Treatment Total Revenue (USD Million) (2017-2018)
Table 33. Mylan SWOT Analysis
Table 34. Mylan Basal Cell Carcinoma Treatment Product and Solutions
Table 35. Mylan Basal Cell Carcinoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Global Basal Cell Carcinoma Treatment Revenue (Million USD) by Players (2015-2020)
Table 37. Global Basal Cell Carcinoma Treatment Revenue Share by Players (2015-2020)
Table 38. Global Basal Cell Carcinoma Treatment Revenue (Million USD) by Regions (2015-2020)
Table 39. Global Basal Cell Carcinoma Treatment Revenue Market Share by Regions (2015-2020)
Table 40. North America Basal Cell Carcinoma Treatment Revenue by Countries (2015-2020)
Table 41. North America Basal Cell Carcinoma Treatment Revenue Market Share by Countries (2015-2020)
Table 42. Europe Basal Cell Carcinoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 43. Asia-Pacific Basal Cell Carcinoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 44. South America Basal Cell Carcinoma Treatment Revenue by Countries (2015-2020)
Table 45. South America Basal Cell Carcinoma Treatment Revenue Market Share by Countries (2015-2020)
Table 46. Middle East and Africa Basal Cell Carcinoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 47. Middle East and Africa Basal Cell Carcinoma Treatment Revenue Market Share by Countries (2015-2020)
Table 48. Global Basal Cell Carcinoma Treatment Revenue (Million USD) by Type (2015-2020)
Table 49. Global Basal Cell Carcinoma Treatment Revenue Share by Type (2015-2020)
Table 50. Global Basal Cell Carcinoma Treatment Revenue Forecast by Type (2021-2025)
Table 51. Global Basal Cell Carcinoma Treatment Revenue by Application (2015-2020)
Table 52. Global Basal Cell Carcinoma Treatment Revenue Share by Application (2015-2020)
Table 53. Global Basal Cell Carcinoma Treatment Revenue Forecast by Application (2021-2025)
Table 54. Global Basal Cell Carcinoma Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Basal Cell Carcinoma Treatment Picture
Figure 2. Global Basal Cell Carcinoma Treatment Revenue Market Share by Type in 2019
Figure 3. Topical Treatment Picture
Figure 4. Hedgehog Pathway Inhibitor Therapy Picture
Figure 5. Mohs Surgery Picture
Figure 6. Other Surgeries Picture
Figure 7. Other Treatments Picture
Figure 8. Basal Cell Carcinoma Treatment Revenue Market Share by Application in 2019
Figure 9. Hospitals Picture
Figure 10. Specialty Clinics Picture
Figure 11. Others Picture
Figure 12. Global Basal Cell Carcinoma Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Basal Cell Carcinoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Basal Cell Carcinoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Basal Cell Carcinoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Basal Cell Carcinoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Basal Cell Carcinoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Basal Cell Carcinoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Basal Cell Carcinoma Treatment Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Basal Cell Carcinoma Treatment Revenue Market Share in 2019
Figure 21. Global Top 10 Players Basal Cell Carcinoma Treatment Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Basal Cell Carcinoma Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Basal Cell Carcinoma Treatment Revenue Market Share by Regions (2015-2020)
Figure 25. Global Basal Cell Carcinoma Treatment Revenue Market Share by Regions in 2018
Figure 26. North America Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Europe Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 29. South America Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 31. North America Basal Cell Carcinoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 32. North America Basal Cell Carcinoma Treatment Revenue Market Share by Countries in 2019
Figure 33. USA Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Canada Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Europe Basal Cell Carcinoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Basal Cell Carcinoma Treatment Revenue Market Share by Countries in 2019
Figure 38. Germany Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 39. UK Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 40. France Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Russia Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Italy Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Basal Cell Carcinoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Basal Cell Carcinoma Treatment Revenue Market Share by Countries in 2019
Figure 45. China Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Japan Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Korea Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 48. India Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 50. South America Basal Cell Carcinoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 51. South America Basal Cell Carcinoma Treatment Revenue Market Share by Countries in 2019
Figure 52. Brazil Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Basal Cell Carcinoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Basal Cell Carcinoma Treatment Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 57. UAE Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Basal Cell Carcinoma Treatment Revenue and Growth Rate (2015-2020)
Figure 60. Global Basal Cell Carcinoma Treatment Revenue Share by Type (2015-2020)
Figure 61. Global Basal Cell Carcinoma Treatment Revenue Share by Type in 2019
Figure 62. Global Basal Cell Carcinoma Treatment Market Share Forecast by Type (2021-2025)
Figure 63. Global Topical Treatment Revenue Growth Rate (2015-2020)
Figure 64. Global Hedgehog Pathway Inhibitor Therapy Revenue Growth Rate (2015-2020)
Figure 65. Global Mohs Surgery Revenue Growth Rate (2015-2020)
Figure 66. Global Other Surgeries Revenue Growth Rate (2015-2020)
Figure 67. Global Other Treatments Revenue Growth Rate (2015-2020)
Figure 68. Global Basal Cell Carcinoma Treatment Revenue Share by Application (2015-2020)
Figure 69. Global Basal Cell Carcinoma Treatment Revenue Share by Application in 2019
Figure 70. Global Basal Cell Carcinoma Treatment Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 72. Global Specialty Clinics Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Basal Cell Carcinoma Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Basal Cell Carcinoma Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Basal Cell Carcinoma Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Basal Cell Carcinoma Treatment Revenue Market Forecast (2021-2025)
Figure 78. Europe Basal Cell Carcinoma Treatment Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Basal Cell Carcinoma Treatment Revenue Market Forecast (2021-2025)
Figure 80. South America Basal Cell Carcinoma Treatment Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Basal Cell Carcinoma Treatment Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
基底細胞がん（BCC）治療薬の世界市場（～2026年） Basal Cell Carcinoma (BCC) is a form of non-melanocytic skin cancer that arises from basal cells, the small, round cells present in the lower epidermis. Around 85% of BCCs occur on the face, head and neck. BCCs usually do not spread or metastasize to other parts of body, they become life threatening…- ハースル細胞がん用治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Hurthle Cell Carcinoma Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hurthle Cell…
- 頭頸部扁平上皮がん (HNSCC)治療の世界市場（～2026年） Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck. Market Analysis and Insights: Global Squamous Cell Carcinoma of the Head and Neck Treatment Market The global S…
- 基底細胞母斑症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Basal Cell Nevus Syndrome Drug Market The global Basal Cell Nevus Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Basal Cell Nevus Syndrome Drug Scope and Market Size …
- 副腎皮質がん治療の世界市場（～2026年） Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. T…